|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4745 | |
| A61K 31/497 | |||
| A61P 35/00 | |||
| A61K 9/00 |
| (11) | Patento numeris | 3389660 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16816563.7 |
| Europos patento paraiškos padavimo data | 2016-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/065503 |
| Data | 2016-12-08 |
| (87) | Numeris | WO 2017/105982 |
| Data | 2017-06-22 |
| (30) | Numeris | Data | Šalis |
| 201562267462 P | 2015-12-15 | US |
| (72) |
BECKMANN, Richard Paul, US
DONOHO, Gregory Paul, US
LIN, Aimee Karis, US
WACHECK, Volker, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | COMBINATION THERAPY FOR CANCER |
| COMBINATION THERAPY FOR CANCER |